Discovery - University of Dundee - Online Publications

Library & Learning Centre

The importance of nonpharmacogenetic factors in endocrine therapy

The importance of nonpharmacogenetic factors in endocrine therapy

Research output: Contribution to journalScientific review

View graph of relations

Info

Original languageEnglish
Pages721-728
Number of pages8
JournalPharmacogenomics
Journal publication dateApr 2012
Journal number6
Volume13
DOIs
StatePublished

Abstract

Nonpharmacogenetic factors may play a key role in the success of oral endocrine therapy for breast cancer. Adherence, defined as following medical advice as well as persistence and duration of use for patients prescribed endocrine therapy, may impact significantly on recurrence and survival. Side effects from tamoxifen or aromatase inhibitors may lead to patients stopping or switching therapy, while comorbidities, consequent coprescribing and patient perceptions may also influence outcomes. Interventions to improve adherence and persistence are required and could have as great an effect on survival as applying pharmacogenetic principles to the endocrine management of breast cancer.

Documents

Library & Learning Centre

Contact | Accessibility | Policy